Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides
- PMID: 1855275
- DOI: 10.1007/BF00685507
Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides
Abstract
Cytotoxic effects of cis-diamminedichloroplatinum-(II) (cis-DDP) are thought to be mediated by binding to DNA. Studies on binding of cis-DDP to cellular DNA rely heavily on the availability of specific antibodies. We therefore raised and characterized four rabbit antisera: one against cis-DDP-modified DNA (antiserum NKI-A59) and three others against the cis-DDP-modified (di)nucleotides cis-Pt(NH3)2d(pApG) (NKI-A68), cis-Pt(NH3)2d(GMP)2 (NKI-A10), and Pt(NH3)3dGMP (NKI-A39). Reactivities to platinum compounds were determined in an enzyme-linked immunosorbent assay (ELISA) and in a quantitative immunocytochemical assay. In the ELISA, NKI-A59 showed a high affinity for DNA heavily substituted with either cis-DDP or CBDCA [cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II)]; amounts of platinum per well giving 50% inhibition (IA50) were as low as 15 and 76 fmol, respectively. NKI-A59 also showed affinity to cis-DDP-modified poly[d(G-C)].poly[d(G-C)], poly(dC), and poly(dG). No affinity was found for trans-DDP [trans-diamminedichloro-platinum(II)]-modified DNA, enzymatically digested cis-DDP-DNA, or cis-DDP-DNA, or cis-DDP-modified poly(dA).poly(dT), oligo(dA)15.oligo(dT)15, oligo(dG)21, oligo(dG)42, or oligo(dAAAG)10. The efficiency of binding to cis-DDP-DNA decreased with decreasing DNA modification levels. Although other cis-DDP-DNA- and cis-DDP-(di)nucleotide-specific antisera have been identified, NKI-A59 is the first antiserum described that is suitable for the in situ detection of cis-DDP-DNA adducts at clinically relevant platinum levels. Adduct-specific immunostaining signals in cultured RIF-1 cells or rat liver paralleled platinum-DNA binding as measured by atomic absorption spectroscopy. The antisera NKI-A68, NKI-A10, and NKI-A39 showed high affinity for their corresponding haptens and varying affinity for non-hapten cis-DDP-DNA adducts. Their affinity for digested cis-DDP-modified DNA was up to 30 times that for intact cis-DDP-DNA. Neither NKI-A68 nor NKI-A10 resulted in specific immunocytochemical staining of cis-DDP-DNA adducts. We conclude that NKI-A68, NKI-A10, and NKI-A39 are suitable for platinum-DNA adduct analysis of digested DNA in ELISA and that NKI-A59 is suitable for platinum-DNA adduct detection at the single-cell level using immunocytochemical methods.
Similar articles
-
Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding.Chem Biol Interact. 1985 Nov;55(3):275-88. doi: 10.1016/s0009-2797(85)80135-6. Chem Biol Interact. 1985. PMID: 4075437
-
Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).Proc Natl Acad Sci U S A. 1987 Dec;84(23):8225-9. doi: 10.1073/pnas.84.23.8225. Proc Natl Acad Sci U S A. 1987. PMID: 2446320 Free PMC article.
-
Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.Carcinogenesis. 1990 Dec;11(12):2117-21. doi: 10.1093/carcin/11.12.2117. Carcinogenesis. 1990. PMID: 1979937
-
Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.Met Ions Biol Syst. 1996;33:105-41. Met Ions Biol Syst. 1996. PMID: 8742842 Review.
-
Immunoassay of carcinogen-modified DNA.Prog Nucleic Acid Res Mol Biol. 1984;31:1-58. doi: 10.1016/s0079-6603(08)60374-8. Prog Nucleic Acid Res Mol Biol. 1984. PMID: 6085171 Review. No abstract available.
Cited by
-
Detection of platinum-DNA adducts by 32P-postlabelling.Nucleic Acids Res. 1995 Apr 25;23(8):1300-6. doi: 10.1093/nar/23.8.1300. Nucleic Acids Res. 1995. PMID: 7753620 Free PMC article.
-
Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.Br J Cancer. 1994 Feb;69(2):235-41. doi: 10.1038/bjc.1994.45. Br J Cancer. 1994. PMID: 8297720 Free PMC article.
-
Immunodetection of human topoisomerase I-DNA covalent complexes.Nucleic Acids Res. 2016 Apr 7;44(6):2816-26. doi: 10.1093/nar/gkw109. Epub 2016 Feb 24. Nucleic Acids Res. 2016. PMID: 26917015 Free PMC article.
-
Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.Chem Res Toxicol. 2009 May;22(5):905-12. doi: 10.1021/tx800481j. Chem Res Toxicol. 2009. PMID: 19323581 Free PMC article.
-
Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy.Cancer Res Commun. 2022 Oct 26;2(10):1266-1281. doi: 10.1158/2767-9764.CRC-22-0208. Cancer Res Commun. 2022. PMID: 36467895 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous